Triple

T20061741
Position Surface form Disambiguated ID Type / Status
Subject BEACOPP regimen E499491 entity
Predicate fullName P16 FINISHED
Object Bleomycin Etoposide Adriamycin Cyclophosphamide Oncovin Procarbazine Prednisone regimen NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Bleomycin Etoposide Adriamycin Cyclophosphamide Oncovin Procarbazine Prednisone regimen | Statement: [BEACOPP regimen, fullName, Bleomycin Etoposide Adriamycin Cyclophosphamide Oncovin Procarbazine Prednisone regimen]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Bleomycin Etoposide Adriamycin Cyclophosphamide Oncovin Procarbazine Prednisone regimen
Context triple: [BEACOPP regimen, fullName, Bleomycin Etoposide Adriamycin Cyclophosphamide Oncovin Procarbazine Prednisone regimen]
  • A. MOPP chemotherapy regimen
    The MOPP chemotherapy regimen is an early combination cancer treatment protocol, historically used for Hodgkin lymphoma, that includes multiple cytotoxic drugs administered in cycles.
  • B. BEACOPP regimen chosen
    The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
  • C. VAC chemotherapy regimen
    The VAC chemotherapy regimen is a combination cancer treatment protocol that typically includes vincristine, actinomycin D (dactinomycin), and cyclophosphamide, commonly used for pediatric solid tumors such as rhabdomyosarcoma.
  • D. ABVD regimen
    The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
  • E. cyclophosphamide
    Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69da6276bcf48190aabbf279192a5fb4 completed April 11, 2026, 3:02 p.m.
NER Named-entity recognition batch_69e6637601dc8190a07fc20844093cb7 completed April 20, 2026, 5:33 p.m.
Created at: April 11, 2026, 3:38 p.m.